相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy' - implications for pre-clinical research and drug testing
Lidia Anguiano Gomez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
Hiddo J. L. Heerspink et al.
KIDNEY INTERNATIONAL (2018)
Therapeutic vaccine against IL-1β improved glucose control in a mouse model of type 2 diabetes
Yue Zhang et al.
LIFE SCIENCES (2018)
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Hans-Joachim Anders et al.
NATURE REVIEWS NEPHROLOGY (2018)
Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
Arpeeta Sharma et al.
FRONTIERS IN PHYSIOLOGY (2018)
Anti-Transforming Growth factor β IgG Elicits a Dual Effects on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Realated Chronic Kidney Disease
Stefanie Steiger et al.
FRONTIERS IN IMMUNOLOGY (2018)
NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice
Ming Wu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
C-C motif-ligand 2 inhibition with emapticap pegol ( NOX-E36) in type 2 diabetic patients with albuminuria
Jan Menne et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
NLRP3 Expression and Urinary HSP72 in Relation to Biomarkers of Inflammation and Oxidative Stress in Diabetic Nephropathy Patients
Hemat El-Sayed El-Horany et al.
IUBMB LIFE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus
Yao Wang et al.
PLOS ONE (2017)
Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts
Natallia Shved et al.
SCIENTIFIC REPORTS (2017)
Fetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling
Jana M. Orellana et al.
PHYSIOLOGICAL REPORTS (2017)
Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications
Santhosh V. R. Kumar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset
Susanne M. Cabrera et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance
Robin P. Choudhury et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease
Hans-Joachim Anders
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Improved kinetic model for the transcutaneous measurement of glomerular filtration rate in experimental animals
Jochen Friedemann et al.
KIDNEY INTERNATIONAL (2016)
Nephron Protection in Diabetic Kidney Disease
Hans-Joachim Anders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Yuan-ye Qiu et al.
PHARMACOLOGICAL RESEARCH (2016)
Optimizing Mouse Surgery with Online Rectal Temperature Monitoring and Preoperative Heat Supply. Effects on Post-Ischemic Acute Kidney Injury
Julian A. Marschner et al.
PLOS ONE (2016)
Innate sensing of oxidation-specific epitopes in health and disease
Christoph J. Binder et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Khurrum Shahzad et al.
KIDNEY INTERNATIONAL (2015)
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
Dick de Zeeuw et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Pattern recognition receptors and the inflammasome in kidney disease
Jaklien C. Leemans et al.
NATURE REVIEWS NEPHROLOGY (2014)
Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2013)
Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: Results of secondary endpoints from a randomized, placebo-controlled trial
J. Hensen et al.
DIABETES & METABOLISM (2013)
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Antoinette Moran et al.
LANCET (2013)
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen A Phase IIb Randomized, Placebo-Controlled Trial
Paul M. Ridker et al.
CIRCULATION (2012)
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Claudia Cavelti-Weder et al.
DIABETES CARE (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Transcutaneous measurement of renal function in conscious mice
Andrea Schreiber et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Dual Blockade of the Homeostatic Chemokine CXCL12 and the Proinflammatory Chemokine CCL2 Has Additive Protective Effects on Diabetic Kidney Disease
Murthy N. Darisipudi et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
XOMA 052, an Anti-IL-1β Monoclonal Antibody, Improves Glucose Control and β-Cell Function in the Diet-Induced Obesity Mouse Model
Alexander M. Owyang et al.
ENDOCRINOLOGY (2010)
Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice
Maciej Lech et al.
INTERNATIONAL IMMUNOLOGY (2010)
Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10
Sufyan G. Sayyed et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Interleukin-1 Resets Glucose Homeostasis at Central and Peripheral Levels: Relevance for Immunoregulation
Hugo O. Besedovsky et al.
NEUROIMMUNOMODULATION (2010)
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Helen J. Lachmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Late onset of Cc12 blockade with the spiegelmer mNOX-E36-3′PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice
Volha Ninichuk et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease:: preliminary experience in France
T. Lequerre et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Claus M. Larsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins
CD Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Quantitative gene expression analysis in renal biopsies: A novel protocol for a high-throughput multicenter application
CD Cohen et al.
KIDNEY INTERNATIONAL (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The role of the interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1
CA Dinarello
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
